Cargando…

Neutrophil-to-lymphocyte ratio is associated with sensitivity to platinum-based chemotherapy and prognosis in patients with advanced serous ovarian carcinoma

The role of the neutrophil-to-lymphocyte ratio (NLR) in predicting sensitivity to chemotherapy and prognosis has attracted great interest in several types of cancer. In the present study, the correlation between pre-chemotherapy NLR and sensitivity to platinum-based chemotherapy and prognosis in pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fukuda, Takeshi, Kawanishi, Masaru, Awazu, Yuichiro, Nanno, Shigenori, Shimomura, Masahiro, Inoue, Yuta, Matsubara, Hiroaki, Yamauchi, Makoto, Kasai, Mari, Hashiguchi, Yasunori, Ichimura, Tomoyuki, Yasui, Tomoyo, Sumi, Toshiyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408678/ https://www.ncbi.nlm.nih.gov/pubmed/34476101 http://dx.doi.org/10.3892/mco.2021.2381

Ejemplares similares

PRMT1 expression predicts response to neoadjuvant chemotherapy for locally advanced uterine cervical cancer
por: Shimomura, Masahiro, et al.
Publicado: (2021)

T-box 2 expression is a useful indicator of the response to neoadjuvant chemotherapy for patients with locally advanced uterine cervical squamous cell carcinoma
por: Inoue, Yuta, et al.
Publicado: (2021)

Uterine metastasis of lobular breast carcinoma under tamoxifen therapy: A case report
por: Awazu, Yuichiro, et al.
Publicado: (2021)

Chemotherapy-induced neutropenia and febrile neutropenia in patients with gynecologic malignancy
por: Hashiguchi, Yasunori, et al.
Publicado: (2015)

Carcinomatous meningitis from ovarian serous carcinoma: A case report
por: Uchikura, Eijiro, et al.
Publicado: (2022)

Fyn expression is associated with the response of patients with locally advanced uterine cervical squamous cell carcinoma to neoadjuvant chemotherapy
por: Nanno, Shigenori, et al.
Publicado: (2022)

CLPTM1L expression predicts recurrence of patients with intermediate‑ and high‑risk stage IB‑IIB cervical cancer undergoing radical hysterectomy followed by TP as adjuvant chemotherapy
por: Awazu, Yuichiro, et al.
Publicado: (2023)

Minimal deviation mucinous adenocarcinoma of the uterine cervix that proved difficult to differentiate from endometrial cancer: A case report
por: NISHII, YUKO, et al.
Publicado: (2014)

A difficult to diagnose case of low-grade endometrial stromal sarcoma with smooth muscle differentiation treated with laparoscopic surgery: A case report
por: Ichimura, Tomoyuki, et al.
Publicado: (2022)

Massive ovarian edema with paraovarian cyst torsion treated with laparoscopic surgery: A case report
por: Fukuda, Takeshi, et al.
Publicado: (2021)

Intestinal‑type mucinous carcinoma of the endometrium showing a polypoidal exophytic form: A case report
por: Nakano, Chiharu, et al.
Publicado: (2023)

Two cases of uterine malignant lymphoma diagnosed by needle biopsy
por: Kasai, Mari, et al.
Publicado: (2015)

Primitive neuroectodermal tumor originating in the vulva: A case report
por: MATSUDA, MAKIKO, et al.
Publicado: (2014)

Metabolic and Morphologic Characteristics of Adipose Tissue Associated with the Growth of Malignant Tumors
por: Ishiko, Osamu, et al.
Publicado: (1999)

PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
por: Morgan, Robert D., et al.
Publicado: (2018)

Ascites-Derived Organoids to Depict Platinum Resistance in Gynaecological Serous Carcinomas
por: Arias-Diaz, Andrea Estrella, et al.
Publicado: (2023)

Deciphering serous ovarian carcinoma histopathology and platinum response by convolutional neural networks
por: Yu, Kun-Hsing, et al.
Publicado: (2020)

High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis
por: Hatano, Yuichiro, et al.
Publicado: (2018)

YKL-40 in the diagnosis, prediction of prognosis, and platinum sensitivity in serous epithelial ovarian cancer
por: Kahramanoğlu, İlker, et al.
Publicado: (2018)

Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
por: Wu, Huan, et al.
Publicado: (2019)

Decreased Levels of GSH Are Associated with Platinum Resistance in High-Grade Serous Ovarian Cancer
por: Criscuolo, Daniela, et al.
Publicado: (2022)

Consensus on the management of platinum-sensitive high-grade serous epithelial ovarian cancer in Lebanon
por: Abdallah, Reem, et al.
Publicado: (2023)

Maternal undernutrition aggravates renal tubular necrosis and interstitial fibrosis after unilateral ureteral obstruction in male rat offspring
por: Awazu, Midori, et al.
Publicado: (2019)

Preoperative Diagnosis of Usual Leiomyoma, Atypical Leiomyoma, and Leiomyosarcoma
por: Matsuda, M., et al.
Publicado: (2014)

Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer
por: Ledermann, Jonathan A, et al.
Publicado: (2016)

Targeting Aurora A Kinase (AAK) in Platinum-Resistant High Grade Serous Ovarian Cancer
por: Ganapathi, Ram N., et al.
Publicado: (2020)

Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
por: Wu, Huan, et al.
Publicado: (2020)

Development of Machine Learning Models to Predict Platinum Sensitivity of High-Grade Serous Ovarian Carcinoma
por: Hwangbo, Suhyun, et al.
Publicado: (2021)

Expression of hormone receptors predicts survival and platinum sensitivity of high-grade serous ovarian cancer
por: Tan, Jiahong, et al.
Publicado: (2021)

Investigating the effect of optimal cytoreduction in the context of platinum sensitivity in high‐grade serous ovarian cancer
por: Cardillo, Nicholas, et al.
Publicado: (2022)

Partial exogastrulation due to apical–basal polarity of F‐actin distribution disruption in sea urchin embryo by omeprazole
por: Watanabe, Kaichi, et al.
Publicado: (2022)

Distinct characteristics of central serous chorioretinopathy according to gender
por: Yoneyama, Seigo, et al.
Publicado: (2022)

Modeling Platinum Sensitive and Resistant High-Grade Serous Ovarian Cancer: Development and Applications of Experimental Systems
por: Cunnea, Paula, et al.
Publicado: (2014)

Reversing Platinum Resistance in High-Grade Serous Ovarian Carcinoma: Targeting BRCA and the Homologous Recombination System
por: Wiedemeyer, W. Ruprecht, et al.
Publicado: (2014)

Chloroxine overrides DNA damage tolerance to restore platinum sensitivity in high-grade serous ovarian cancer
por: Silva, Vera L., et al.
Publicado: (2021)

Tuberous Sclerosis Complex Associated with Papillary Serous Carcinoma of the Peritoneum, Lymphangioleiomyomatosis, and Angiomyolipoma
por: Wakamiya, Tomihiro, et al.
Publicado: (2011)

Late recurrence of pStage 1 low-grade serous ovarian tumor presenting as a symptomatic bone metastasis: a case report
por: Kubo, Chiaki, et al.
Publicado: (2018)

Metabolism of Estrogens: Turnover Differs between Platinum-Sensitive and -Resistant High-Grade Serous Ovarian Cancer Cells
por: Poschner, Stefan, et al.
Publicado: (2020)

SLFN11 captures cancer-immunity interactions associated with platinum sensitivity in high-grade serous ovarian cancer
por: Winkler, Claudia, et al.
Publicado: (2021)

Morphologic and molecular correlates of EZH2 as a predictor of platinum resistance in high-grade ovarian serous carcinoma
por: Reid, Brett M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lpmac0r9hhgt71u680kphgl813